000			01594nam a22002057a 4500
999			_c2220 _d2220
003			OSt
005			20191226214828.0
008			111018t xxu||||| |||| 00| 0 eng d
020			_a9789241563611
020			_a9241563613
060			_aWF 360 A 2008
245	1	0	_aAnti-tuberculosis drug resistance in the world : _bfourth global report.
260			_aGeneva, Switzerland : _bWorld Health Organization, _c2008.
300			_a151 p. : _bill. ; _c24 cm.
504			_aIncludes bibliographical references (p. 97-100).
520			_aMultidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to this new report that presents findings from the largest survey to date on the scale of drug resistance in tuberculosis. This fourth global report is based on information collected between 2002 and 2006 on 90,000 TB patients in 81 countries. It also found that extensively drug-resistant tuberculosis (XDR-TB), a virtually untreatable form of the respiratory disease, has been recorded in 45 countries. The primary aim of this report is to share survey and surveillance data on drug resistance in TB. The data presented here are supplied largely by the program managers who have led the work on surveys, but also heads of reference laboratories as well as principle investigators that may have been hired to assist the national Tuberculosis Program with the study.
650		0	_aTuberculosis
942			_2NLM _cWHO PUB